India In Vitro Diagnostics (IVD) Quality Control Market (2025-2030)
The India In Vitro Diagnostics (IVD) Quality Control Market was valued at $40.3 Million in 2025 and projected to reach to $58.6 Million by 2030, representing a compound annual growth rate of 7.8%. India's In Vitro Diagnostics Quality Control Market is poised for sustained growth through 2030, supported by structural healthcare reforms and digital transformation initiatives.
India In Vitro Diagnostics (IVD) Quality Control Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 7.8%, significantly outpacing global market growth.
- India's rapid healthcare infrastructure development, increasing diagnostic laboratory penetration, and rising demand for accurate quality assurance in diagnostic testing are driving this accelerated expansion. The Indian market benefits from a growing population, expanding middle class, and heightened awareness of diagnostic accuracy standards.
- India's emphasis on laboratory accreditation and regulatory compliance is propelling investments in quality control solutions across diagnostic centers, hospitals, and reference laboratories.
- The forecast period through 2030 indicates sustained momentum as India strengthens its position as a key healthcare diagnostics hub in the Asia Pacific region..
Key Market Statistics
- CAGR (2025-2030) 7.8% CAGR
- Market Size, 2025 ~USD 40.3 Million
- Forecast, 2030 ~USD 58.6 Million
- Country India
India In Vitro Diagnostics (IVD) Quality Control Market Overview
Fastest Growing Market Segment :
India's IVD Quality Control Market is expanding at 7.8% CAGR, significantly outpacing the global growth rate of 5.5%, driven by rapid healthcare modernization and diagnostic laboratory expansion across tier-2 and tier-3 cities.
Substantial Market Valuation Growth :
The market is projected to grow from USD 40.3 million in 2025 to USD 58.6 million by 2030, representing a 45.4% increase over five years, reflecting strong demand for quality assurance in diagnostic testing.
Healthcare Infrastructure Development :
India's aggressive expansion of diagnostic laboratory networks, coupled with government initiatives like Ayushman Bharat and increased healthcare spending, is creating unprecedented demand for IVD quality control solutions.
Rising Diagnostic Penetration :
Increasing awareness of preventive healthcare, growing middle-class population, and rising disease prevalence are driving higher diagnostic testing volumes, necessitating robust quality control mechanisms across laboratories.
India In Vitro Diagnostics (IVD) Quality Control Market Dynamics
- The country's expanding diagnostic laboratory infrastructure, particularly in emerging metropolitan areas, combined with stringent regulatory requirements from bodies like NABL and CLIA, is accelerating adoption of advanced quality control systems.
- Increasing investments in healthcare technology and rising laboratory automation are expected to further propel market expansion. The market will benefit from India's position as a global diagnostic hub and the growing emphasis on standardization and accreditation.
- Rising healthcare expenditure, coupled with increasing patient awareness about diagnostic accuracy, will drive demand for sophisticated quality control solutions.
- Strategic partnerships between domestic and international players, along with government support for laboratory infrastructure development, will create significant growth opportunities through 2030..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- India's IVD Quality Control Market is valued at USD 40.3 million in 2025 and expected to grow to USD 58.6 million by 2030 at a 7.8% CAGR.
- India's market growth rate of 7.8% significantly exceeds the global CAGR of 5.5%, reflecting strong regional demand and healthcare modernization.
- India's expanding diagnostic laboratory infrastructure and regulatory compliance requirements are primary catalysts for quality control solution adoption.
- India's position as a healthcare diagnostics hub in Asia Pacific is strengthened by rising middle-class healthcare spending and laboratory accreditation initiatives.
In Vitro Diagnostics (IVD) Quality Control Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.5% from 2025 to 2030 |
| Largest Segment | QUALITY CONTROL PRODUCTS (Product & Service) |
| Market Size Base Year (Billions) | ~USD 1.65 (2025) |
| Revenue Forecast (Billions) | ~USD 2.15 (2030) |
| Segments Covered | Product & Service, Type, Technology, Manufacturer Type, End User |
India In Vitro Diagnostics (IVD) Quality Control Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Data Management Solutions
- Quality Assurance Services
- Quality Control Products
By Type
- Independent Controls
- Instrument-Specific Controls
- Other Controls
- Serum/Plasma-Based Controls
- Urine-Based Controls
- Whole Blood-Based Controls
By Technology
- Clinical Chemistry
- Coagulation & Hemostasis
- Hematology
- Immunoassays
- Microbiology
- Molecular Diagnostics
- Other Technologies
By Manufacturer Type
- Original Equipment Manufacturer Controls
- Third-Party Controls
By End User
- Academic & Research Institutes
- Clinical Laboratories
- Hospitals
- Other End Users
Target Audience
- IVD Equipment Manufacturers : Manufacturers of quality control instruments and reagents need India-specific market data to identify growth opportunities, assess competitive positioning, and develop localized product strategies for the expanding diagnostic laboratory sector.
- Diagnostic Laboratory Operators : Laboratory chains and independent diagnostic centers require market insights to benchmark quality control investments, understand regulatory compliance trends, and optimize operational efficiency in India's competitive diagnostic landscape.
- Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in India's healthcare diagnostics sector need comprehensive market analysis to assess growth potential, identify acquisition targets, and make informed capital allocation decisions.
- Regulatory & Compliance Consultants : Consultants advising diagnostic facilities on quality standards and accreditation need India-specific market data to guide clients on compliance investments, regulatory trends, and best practices in quality control implementation.
- Healthcare Policy Makers : Government agencies and health policy officials require market intelligence to develop evidence-based policies for diagnostic standardization, laboratory accreditation, and quality assurance frameworks supporting India's healthcare objectives.
Key Companies in the India In Vitro Diagnostics (IVD) Quality Control Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOMERIEUX S.A. | France | Public Company | Clinical microbiology (VITEK, culture media, ID/AST, BACT/ALERT),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, NUCLISENS),Immunoassays and biomarkers (VIDAS, Hybiome CLIA, sepsis markers), |
| CEPHEID INC. | United States | Private Company | GeneXpert instruments and Xpert test cartridges,SmartCycler systems and assays,Collaborative and program-based solutions (e.g., TB, Ebola, USPS BDS), |
| IMMUCOR, INC. | United States | Private Company | Transfusion (serology instruments and reagents),Transplant & Molecular (HLA, HEA/HPA typing, Array Imaging System),Platelet-focused and specialty coagulation products, |
| DIASORIN | Italy | Public Company | Immunodiagnostics – Infectious and Gastrointestinal Diseases,Immunodiagnostics – Endocrinology and Metabolic Disorders,Oncology and Tumor Markers, |
| UNILABS | Switzerland | Private Company | Core laboratory testing,Medical imaging services,Pathology and centres of excellence, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Research Instruments and Reagents,Other and Services, |
| THERMO FISHER SCIENTIFIC, INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| ABBOTT | United States | Public Company | Diagnostic Products (core lab, rapid, molecular, cardiometabolic, drug testing),Medical Devices (cardiovascular, diabetes care, neuromodulation),Nutritional Products (pediatric, adult, infant formula), |
| LGC LIMITED | South Korea | Public Company | Ethylene-based synthetic resins (EVA, HDPE, LDPE, LLDPE, POE, metallocene PE, UNIQABLE),Styrene-based resins (ABS, ASA, EPS, PS, SAN),Polycarbonate and polypropylene, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| QUIDELORTHO CORPORATION | United States | Public Company | Labs (clinical chemistry and immunoassay),Transfusion Medicine,Point of Care (professional and OTC), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicines),Diagnostics (clinical instruments and consumables), |
| SYSMEX CORPORATION | Japan | Public Company | Hematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx),Coagulation systems and reagents,Blood gas, electrolyte, and urinalysis analyzers, |
| BIO-TECHNE CORPORATION | United States | Public Company | Protein Sciences reagents (cytokines, growth factors, antibodies, small molecules, sera, cell selection),Proteomic and protein analysis instruments and immunoassays,Diagnostics products, controls, calibrators, and assays, |
| MICROBIX BIOSYSTEMS INC. | Canada | Public Company | Antigen and test ingredient business,QAPs branded test controls and quality assessment products,DxTM viral transport medium, |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
BIOMERIEUX S.A.
bioMérieux S.A. is a French public company founded in 1963 that employs 14,894 people. The company operates in the diagnostics and life sciences sector.
CEPHEID INC.
Cepheid Inc. is a private company founded in 1996 in the United States with 1,700 employees. The company specializes in molecular diagnostics and infectious disease testing.
IMMUCOR, INC.
Immucor, Inc. is a private company founded in 1982 in the United States with 1,125 employees. The company focuses on blood bank and transfusion diagnostics.
DIASORIN
DiaSorin is an Italian public company founded in 1968 with 3,242 employees. The company operates in the in vitro diagnostics sector.
UNILABS
Unilabs is a private company founded in 1987 in Switzerland with 1,897 employees. The company provides laboratory and diagnostic services.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a public company founded in 1952 in the United States with 7,450 employees. The company develops and manufactures life science research and clinical diagnostics products.
THERMO FISHER SCIENTIFIC, INC.
Thermo Fisher Scientific, Inc. is a public company founded in 1956 in the United States with 125,000 employees. The company is a global leader in serving science with laboratory equipment, reagents, and analytical instruments.
ABBOTT
Abbott is a public company founded in 1888 in the United States with 115,000 employees. The company operates in diagnostics, medical devices, pharmaceuticals, and nutritional products.
LGC LIMITED
LGC Limited is a public company founded in 1947 in South Korea with 14,019 employees. The company provides testing, proficiency testing, and reference materials services.
SIEMENS HEALTHINEERS AG
Siemens Healthineers AG is a public company founded in 1896 in Germany with 72,369 employees. The company provides medical imaging, laboratory diagnostics, and point-of-care testing solutions.
QUIDELORTHO CORPORATION
QuidelOrtho Corporation is a public company founded in 1979 in the United States with 6,500 employees. The company develops and manufactures rapid diagnostic tests and molecular testing solutions.
DANAHER CORPORATION
Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees. The company operates across diagnostics, life sciences, and environmental and applied solutions segments.
SYSMEX CORPORATION
Sysmex Corporation is a public company founded in 1968 in Japan with 10,861 employees. The company manufactures hematology analyzers and other in vitro diagnostic systems.
BIO-TECHNE CORPORATION
Bio-Techne Corporation is a public company founded in 1976 in the United States with 3,100 employees. The company develops and manufactures life science tools and bioanalytical instruments.
MICROBIX BIOSYSTEMS INC.
Microbix Biosystems Inc. is a public company founded in 1988 in Canada with 100 employees. The company produces quality control materials and reference standards for diagnostics.
GRIFOLS, S.A.
Grifols, S.A. is a public company founded in 1909 in Spain with 25,000 employees. The company specializes in blood plasma derivatives and diagnostic products.
Reasons to Buy this Report
- India-Specific Market Sizing : Obtain precise valuation data for India's IVD Quality Control Market with verified estimates for 2025 (USD 40.3M) and 2030 (USD 58.6M), enabling accurate financial forecasting and investment planning specific to the Indian market.
- Competitive Landscape Intelligence : Understand the competitive dynamics, key players, and market consolidation trends specific to India's diagnostic quality control sector, identifying partnership and acquisition opportunities in this high-growth market.
- Regulatory & Compliance Insights : Navigate India's complex regulatory environment including NABL accreditation, CLIA standards, and government quality mandates with detailed analysis of compliance requirements driving market demand and investment priorities.
- Growth Driver Analysis : Identify and quantify India-specific growth catalysts including healthcare infrastructure expansion, diagnostic laboratory penetration in tier-2/3 cities, and government health initiatives influencing market trajectory through 2030.
- Strategic Market Entry Planning : Develop informed market entry strategies with India-focused insights on customer segments, distribution channels, pricing dynamics, and regional variations to maximize ROI in this rapidly expanding diagnostic quality control market.
Frequently asked questions
What is the current market size of IVD Quality Control in India?
India's IVD Quality Control Market is valued at USD 40.3 million in 2025, with verified data confirming this baseline for market analysis and forecasting.
What is the projected market size for India's IVD Quality Control Market by 2030?
India's IVD Quality Control Market is projected to reach USD 58.6 million by 2030, representing significant growth over the five-year forecast period.
What is the CAGR for India's IVD Quality Control Market?
India's IVD Quality Control Market is growing at a compound annual growth rate (CAGR) of 7.8%, outpacing the global average of 5.5%.
What factors are driving growth in India's IVD Quality Control Market?
India's market growth is driven by expanding diagnostic laboratory infrastructure, increasing regulatory compliance requirements, rising healthcare spending, and growing awareness of diagnostic accuracy standards.
How does India's market growth compare to global trends?
India's 7.8% CAGR significantly exceeds the global market CAGR of 5.5%, indicating India as a high-growth region within the Asia Pacific segment.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global IVD quality controls market.
Exhaustive secondary research was done to collect information on the IVD quality controls market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the IVD quality controls market.
The four steps involved in estimating the market size are as follows:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. Here’s the breakdown of tiers: Tier 1 = > USD 100 million, tier 2 = USD 10 million to USD 100 million, and tier 3 = < USD 10 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the IVD quality controls market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size included the following:
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
IVD quality controls are standardized materials used to monitor, evaluate, and ensure the accuracy, reliability, and precision of diagnostic testing processes in clinical laboratories. These controls are designed to mimic patient samples and are produced from human-derived matrices such as serum, plasma, urine, or whole blood. IVD quality controls provide a benchmark for validating test system performance, detecting errors, and ensuring regulatory compliance across diverse diagnostic platforms.
Stakeholders
- Senior Management
- End Users
- Finance/Procurement Department
- R&D Department
Report Objectives
- To define, describe, segment, and forecast the global IVD quality controls market by product & service, technology, manufacturer type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall IVD quality controls market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the IVD quality controls market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
Get the Full In Vitro Diagnostics (IVD) Quality Control Market Report
Full forecast, segment splits, and company analysis for all In Vitro Diagnostics (IVD) Quality Control Market.
- Canada In Vitro Diagnostics (IVD) Quality Control Market
- US In Vitro Diagnostics (IVD) Quality Control Market
- Germany In Vitro Diagnostics (IVD) Quality Control Market
- UK In Vitro Diagnostics (IVD) Quality Control Market
- France In Vitro Diagnostics (IVD) Quality Control Market
- Italy In Vitro Diagnostics (IVD) Quality Control Market
- Spain In Vitro Diagnostics (IVD) Quality Control Market
- Russia In Vitro Diagnostics (IVD) Quality Control Market
- China In Vitro Diagnostics (IVD) Quality Control Market
- Japan In Vitro Diagnostics (IVD) Quality Control Market
- Australia In Vitro Diagnostics (IVD) Quality Control Market
- South Korea In Vitro Diagnostics (IVD) Quality Control Market
- Brazil In Vitro Diagnostics (IVD) Quality Control Market
- Mexico In Vitro Diagnostics (IVD) Quality Control Market
- Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Market
- UAE In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Europe In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report